Medra

MedraMedra
Medra

Medra

AI-powered platform that automates drug discovery through physical AI scientists and robotic experimentation.

2021Active20
Rate

About

Medra develops Physical AI Scientists that autonomously conduct biological experiments using robotics and AI. The platform integrates scientific reasoning with physical execution, enabling continuous learning and faster iteration in drug discovery. It aims to accelerate the development of therapeutics by creating a closed-loop system for hypothesis generation, experimental validation, and optimization.

Technology stack

detected 2026-07-07
CDN
Cloudflare
EmailGoogle Workspace
Stack
Webflow
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Medra do?

Medra develops Physical AI Scientists that autonomously conduct biological experiments using robotics and AI. The platform integrates scientific reasoning with physical execution, enabling continuous learning and faster iteration in drug discovery. It aims to accelerate the development of therapeutics by creating a closed-loop system for hypothesis generation, experimental validation, and optimization.

How much funding has Medra raised?

Medra has raised a total of $63M in funding. The most recent round on record is Series A.

Where is Medra headquartered?

Medra is headquartered in San Francisco, CA.

When was Medra founded?

Medra was founded in 2021.

What industry does Medra operate in?

Medra operates in Healthcare AI, Clinical Documentation, Biotech, HealthTech, Robotics, Drug Discovery.

How many employees does Medra have?

Medra has approximately 20 people on record.

What is Medra's valuation?

StartupHub estimates Medra's effective valuation at $263.0M (range $157.5M to $378.0M, 20% confidence), based on comparable companies in the sector.